NDC 63323-288-01 - Naropin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-288
- Requested NDC
- 63323-288-01
- Package NDCs from labels
- 63323-288-01, 63323-288-10, 63323-288-06, 63323-288-20, 63323-288-03, 63323-288-11, 63323-288-07, 63323-288-21, 63323-288-23, 63323-288-29, 63323-288-25, 63323-288-27
- Manufacturer
- Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS
- Effective date
- 2024-08-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | 2024-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | HP Halden Pharma AS | Fresenius Kabi USA, LLC | HP Halden Pharma AS | 2024-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | 2011-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-288-01 | Naropin | 10 mL in 1 AMPULE | INJECTION, SOLUTION | 10 | 27 | |
| 63323-288-03 | Naropin | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 27 | |
| 63323-288-06 | Naropin | 20 mL in 1 AMPULE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-288-07 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-288-10 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-288-11 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-288-20 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-288-21 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-288-23 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 8 | |
| 63323-288-29 | Naropin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 8 | |
| 63323-288-25 | Naropin | 20 mL in 1 AMPULE | INJECTION, SOLUTION | 20 | 5 | |
| 63323-288-27 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-288 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 27 | Current NDC, Legacy NDC, 8 package rows | 20240814_23d2d448-a744-4877-9f2d-7e57c198da89.zip |
| 63323-288 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 8 | Current NDC, Legacy NDC, 2 package rows | 20240817_c6613708-c1f7-4f5c-91a3-ebbc1d7905c6.zip |
| 63323-288 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240524_56dfabf7-f7a8-4601-b17a-cb16fb995b0f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-288-01 | ML - Milliliter | 63323-288 | 99d30a29-0827-4f56-871e-74fff2b21d2a | 1 | 2025-09-12 |
| 63323-288-06 | ML - Milliliter | 63323-288 | 0b27ce34-0c40-470b-baa5-cd6d736138a9 | 1 | 2021-06-02 |
| 63323-288-07 | ML - Milliliter | 63323-288 | e450eecd-0e8b-4c29-8b4e-70132736db56 | 1 | 2024-08-12 |
| 63323-288-10 | ML - Milliliter | 63323-288 | 3332880c-79cc-46fc-b3fe-0d5e98caedb9 | 1 | 2012-07-24 |
| 63323-288-11 | ML - Milliliter | 63323-288 | cfbf6146-ab02-4290-b393-9e6cf57f0bdb | 1 | 2013-02-13 |
| 63323-288-20 | ML - Milliliter | 63323-288 | d1bf23e5-a796-4fd1-be7d-d04e794afc02 | 1 | 2012-07-24 |
| 63323-288-21 | ML - Milliliter | 63323-288 | 28b72b1c-78b4-463a-baf5-f1249b7071d8 | 1 | 2013-02-13 |
| 63323-288-23 | ML - Milliliter | 63323-288 | 57c7d0ae-4b9d-4fa9-a9b4-015794be2d20 | 1 | 2024-07-12 |
| 63323-288-27 | ML - Milliliter | 63323-288 | 67d56f56-df1f-4127-896a-1e29cb3fd63f | 1 | 2014-04-03 |
| 63323-288-29 | ML - Milliliter | 63323-288 | f2b1e7d0-d777-41f2-a2a2-b4a33d62a096 | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X | |
| c5a1ce28-2785-45e2-ad20-32dd83b626ea | f27790b5-cdb9-4fd2-b575-70686a5cbb58 | 2011-09-15 | Warnings, Adverse reactions | c5a1ce28-2785-45e2-ad20-32dd83b626ea f27790b5-cdb9-4fd2-b575-70686a5cbb58 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.